drug
gepirone hydrochloride ER
Marketedupdated 3mo agoby Fabre-Kramer Pharmaceuticals Inc
Approvedcommunity read0 votes
indications
investigational
Major Depression
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 22, 2028
~2.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Sep 2, 2030method-of-use (U-3699)US 75381164.1y
- Sep 2, 2030method-of-use (U-3699)US 75381164.1y
- Sep 2, 2030method-of-use (U-3699)US 75381164.1y
- Sep 2, 2030method-of-use (U-3699)US 75381164.1y
FDA exclusivities (4)
- Sep 22, 2028NCENew Chemical Entity (5y)2.2y
- Sep 22, 2028NCENew Chemical Entity (5y)2.2y
- Sep 22, 2028NCENew Chemical Entity (5y)2.2y
- Sep 22, 2028NCENew Chemical Entity (5y)2.2y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that